- Home
- RVTY vs QGEN Comparison
RVTY vs QGEN Comparison
Compare RVTY & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVTY
- QGEN
- Stock Information
- Founded
- RVTY 1937
- QGEN 1986
- Country
- RVTY United States
- QGEN Netherlands
- Employees
- RVTY N/A
- QGEN N/A
- Industry
- RVTY Biotechnology: Laboratory Analytical Instruments
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RVTY Industrials
- QGEN Health Care
- Exchange
- RVTY Nasdaq
- QGEN Nasdaq
- Market Cap
- RVTY 9.9B
- QGEN 10.3B
- IPO Year
- RVTY N/A
- QGEN 1996
- Fundamental
- Price
- RVTY $93.33
- QGEN $46.97
- Analyst Decision
- RVTY Buy
- QGEN Buy
- Analyst Count
- RVTY 14
- QGEN 8
- Target Price
- RVTY $117.86
- QGEN $51.01
- AVG Volume (30 Days)
- RVTY 1.2M
- QGEN 1.1M
- Earning Date
- RVTY 10-27-2025
- QGEN 11-05-2025
- Dividend Yield
- RVTY 0.30%
- QGEN 3.22%
- EPS Growth
- RVTY 72.56
- QGEN 405.09
- EPS
- RVTY 2.37
- QGEN 1.69
- Revenue
- RVTY $2,798,467,000.00
- QGEN $2,040,067,000.00
- Revenue This Year
- RVTY $5.55
- QGEN $7.37
- Revenue Next Year
- RVTY $4.06
- QGEN $5.70
- P/E Ratio
- RVTY $40.67
- QGEN $27.64
- Revenue Growth
- RVTY 3.33
- QGEN 5.15
- 52 Week Low
- RVTY $81.36
- QGEN $37.63
- 52 Week High
- RVTY $129.50
- QGEN $51.88
- Technical
- Relative Strength Index (RSI)
- RVTY 62.35
- QGEN 56.60
- Support Level
- RVTY $82.47
- QGEN $43.74
- Resistance Level
- RVTY $94.92
- QGEN $46.23
- Average True Range (ATR)
- RVTY 2.62
- QGEN 0.67
- MACD
- RVTY 1.22
- QGEN 0.32
- Stochastic Oscillator
- RVTY 87.23
- QGEN 96.42
About RVTY Revvity Inc.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).